当前位置: X-MOL 学术Hemodial. Int. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A rare case of Actinomyces skin and soft tissue infection in an end-stage kidney disease patient with a review of the literature.
Hemodialysis International ( IF 1.3 ) Pub Date : 2020-05-26 , DOI: 10.1111/hdi.12843
Leon Hsueh 1, 2 , Sumanth Kacharam 2, 3 , Ankur D Shah 2, 3
Affiliation  

End‐stage kidney disease (ESKD) patients are a commonly overlooked immunocompromised population that places them at risk for rare infections. We describe the case of a 78‐year‐old man with a history of ESKD managed with thrice weekly in‐center hemodialysis who had a prolonged episode of left elbow pain and drainage and was eventually found to have a skin and soft tissue infection from Actinomyces radingae. We review the bacteriology of Actinomyces spp. and the experiences of other providers who have treated actinomycosis in individuals with ESKD. The anatomic sites and demographics of these individuals are heterogeneous, but they all generally require a long antibiotic course with a beta‐lactam and portend to a good prognosis. High index of suspicion is needed to identify rare and atypical infections in the ESKD population.

中文翻译:

终末期肾脏疾病患者中放线菌属皮肤和软组织感染的罕见病例,文献综述。

终末期肾脏病(ESKD)患者是一个普遍被忽视的免疫功能低下的人群,使他们面临罕见感染的风险。我们描述了一个患有ESKD病史的78岁男子的案例,该病每周进行三次中心血液透析,左肘疼痛和引流时间延长,最终被放线菌感染并感染了皮肤和软组织radingae。我们回顾放线菌的细菌学spp。以及其他曾在ESKD患者中治疗过放线菌病的医疗服务提供者的经验。这些个体的解剖学部位和人口统计学是异质的,但是它们通常都需要长期的抗生素疗程以及β-内酰胺,预示着良好的预后。为了确定ESKD人群中的罕见和非典型感染,需要高度怀疑。
更新日期:2020-05-26
down
wechat
bug